ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,599,000 | -31.3% | 113,773 | -2.3% | 0.18% | -10.4% |
| Q2 2015 | $6,699,000 | -11.9% | 116,403 | -2.6% | 0.20% | -7.4% |
| Q1 2015 | $7,607,000 | -49.4% | 119,473 | -51.0% | 0.22% | -48.3% |
| Q4 2014 | $15,043,000 | +31.1% | 243,653 | -17.5% | 0.42% | +37.7% |
| Q3 2014 | $11,471,000 | +10.2% | 295,413 | -2.3% | 0.30% | +19.6% |
| Q2 2014 | $10,412,000 | -27.8% | 302,243 | -9.5% | 0.26% | -18.8% |
| Q1 2014 | $14,423,000 | +0.6% | 333,799 | -7.3% | 0.31% | +2.6% |
| Q4 2013 | $14,343,000 | +0.7% | 360,020 | -5.1% | 0.31% | +1.3% |
| Q3 2013 | $14,242,000 | – | 379,376 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |